On the role of the second coding exon of the HIV-1 tat protein in virus replication and MHC class I downregulation

AIDS Research and Human Retroviruses

Volumn 14, Issue 17, 1998, Pages 1553-1559

  Verhoef, Koen ^a   Bauer, Monica ^b   Meyerhans, Andreas ^b   Berkhout, Ben ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; EXON; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE; VIRUS REPLICATION;

EID: 0032553475     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.1553     Document Type: Article

References (43)

1. Jeang KT, Chang Y, Berkhout B, Hammarskjold ML, and Rekosh D: Regulation of HIV expression: Mechanisms of action of Tat and Rev. AIDS 1991;5(Suppl. 2):S3-14. [Review]
2. Cullen BR: Does HIV-1 Tat induce a change in viral initiation rights. Cell 1993;73:417-420.
3. Seigel LJ, Ratner L, Josephs SF, Derse D, Feinberg MB, Reyes GR, O'Brien SJ, and Wong-Staal F: Trans-activation induced by human T-lymphotrophic virus type III (HTLV-III) maps to a viral sequence encoding 58 amino acids and lacks tissue specificity. Virology 1986;148:226-231.
4. Hauber J, Malim M, and Cullen B: Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein. J Virol 1989;63:1181-1187.
5. Ruben S, Perkins A, Purcell R, Joung K, Sia R, Burghoff R, Haseltine W, and Rosen C: Structural and functional analysis of human immunodeficiency virus tat protein. J Virol 1989;63:1-8.
6. Kuppuswamy M, Subramanian T, Srinivasan A, and Chinnadurai G: Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis. Nucleic Acids Res 1989;17: 3551-3561.
7. Garcia JA, Harrich D, and Gaynor RB: Functional domains required for tat-induced transcriptional activation of the HIV 1 long terminal repeat. EMBO J 1988;7:3143-3147.
8. Jeang KT, Berkhout B, and Dropulic B: Effects of integration and replication on transcription of the HIV-1 long terminal repeat. J Biol Chem 1993;268:24940-24949.
9. Chang HK, Gallo RC, and Ensoli B: Regulation of cellular gene expression and function by the human immunodeficiency virus type 1 Tat protein. J Biomed Sci 1995;2:189-202.
10. Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, and Gallo RC: Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 1993;67:277-287.
11. Marcuzzi A, Weinberger J, and Weinberger OK: Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in cocultured lymphocytes. J Virol 1992;66:4228-4232.
12. Heiland DE, Welles JL, Caputo A, and Haseltine WA: Transcellular transactivation by the human immunodeficiency virus type 1 Tat protein. J Virol 1991;65:4547-4549.
13. Verhoef K, Klein A, and Berkhout B: Paracrine activation of the HIV-1 LTR promoter by the viral Tat protein is mechanistically similar to trans-activation within a cell. Virology 1996;225: 316-327.
14. Howcroft TK, Strebel K, Martin MA, and Singer DS: Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science 1993;260:1320-1322.
15. Ciminale V, Felber BK, Campbell M, and Pavlakis GN: A bioassay for HIV-1 based on Env-CD4 interaction. AIDS Res Hum Retroviruses 1990;6:1281-1287.
16. Back NKT, Nijhuis M, Keulen W, Boucher CAB, Oude Essink BB, van Kuilenburg ABP, Van Gennip AH, and Berkhout B: Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. EMJO J 1996;15:4040-4049.
17. Berkhout B and Jeang KT: Trans activation of human immunodeficiency virus type 1 is sequence specific for both the single-stranded bulge and loop of the trans-acting-responsive hairpin: A quantitative analysis. J Virol 1989;63:5501-5504.
18. Nietfeld W, Bauer M, Fevrier M, Maier R, Holzwarth B, Frank R, Maier B, Riviere Y, and Meyerhans A: Sequence constraints and recognition by cytotoxic T lymphocytes of an HLA-B27 restricted HIV-1 Gag epitope. J Immunol 1995;154:2188-2197.
19. Verhoef K, Koper M, and Berkhout B: Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication. Virology 1997;237:228-236.
20. Koken SEC, van Wamel J, and Berkhout B: A sensitive promoter assay based on the transcriptional activator Tat of the HIV-1 virus. Gene 1994;144:243-247.
21. Kunkel TA: Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci USA 1985;82:488-492.
22. Klaver B and Berkhout B: Comparison of 5′ and 3′ long terminal repeat promoter function in human immunodeficiency virus. J Virol 1994;68:3830-3840.
23. Seed B and Sheen JY: A simple phase-extraction assay for chloramphenicol acyltransferase activity. Gene 1988;67:271-277.
24. Berkhout B and Klaver B: In vivo selection of randomly mutated retroviral genomes. Nucleic Acids Res 1993;21:5020-5024.
25. Harrigan PR, Bloor S, and Larder BA: Relative replication fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro. J Virol 1998;72:3773-3778.
26. Koken SEC, van Wamel JL, Goudsmit J, Berkhout B, and Geelen JL: Natural variants of the HIV-1 long terminal repeat: Analysis of promoters with duplicated DNA regulatory motifs. Virology 1992;191:968-972.
27. Scheppler JA, Nicholson JKA, Swan DC, Ahmed-Ansari A, and McDougal JS: Down-modulation of MHC-1 in a CD4+ T cell line, Cem-E5, after HIV-1 infection. J Immunol 1989;143:2858-2866.
28. Yang OO, Kalams SA, Rosenzweig M, Trocha A, Jones N, Koziel M, Walker BD, and Johnson RP: Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes. J Virol 1996;70:5799-5806.
29. Schwanz O, Marechal V, Le Gall S, Lemonnier F, and Heard J-M: Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nature Med 1996; 2:338-342.
30. Collins KL, Chen BK, Kalams SA, Walker BD, and Baltimore D: HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature (London) 1998;391:397-401.
31. Subramanian RA and Cohen EA: Molecular biology of the human immunodeficiency virus accessory proteins. J Virol 1994;68:6831-6835.
32. Neuveut C and Jeang K-T: Recombinant human immunodeficiency virus type 1 genomes with Tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture. J Virol 1996;70:5572-5581.
33. Verhoef K, Tijms M, and Berkhout B: Optimal Tat-mediated activation of the HIV-1 LTR promoter requires a full-length TAR RNA hairpin. Nucleic Acids Res 1997;25:496-502.
34. Frankel AD, Biancalana S, and Hudson D: Activity of synthetic peptides from the Tat protein of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1989;86:7397-7401.
35. Jeyapaul J, Reddy MR, and Khan SA: Activity of synthetic Tat peptides in human immunodeficiency virus type 1 long terminal repeat-promoted transcription in a cell-free system. Proc Natl Acad Sci USA 1990;87:7030-7034.
36. Kim YS and Panganiban AT: The full-length Tat protein is required for TAR-independent, posttranscriptional trans activation of human immunodeficiency virus type 1 env gene expression. J Virol 1993;67:3739-3747.
37. Rhim H and Rice AP: Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA. Nucleic Acids Res 1994;22:4405-4413.
38. Tong Starksen SE, Baur A, Lu XB, Peck E, and Peterlin BM: Second exon of Tat of HIV-2 is required for optimal trans-activation of HIV-1 and HIV-2 LTRs. Virology 1993;195:826-830.
39. Rinaldo CR: Modulation of major histocompatibility complex antigen expression by viral infection. Am J Pathol 1994;144:637-650.
40. Howcroft TK, Palmer LA, Brown J, Rellahan B, Kashanchi F, Brady JN, and Singer DS: HIV Tat represses transcription through Sp1-like elements in the basal promoter. Immunity 1995;3:127-138.
41. Kerkau T, Schmitt-Landgraf R, Schimpl A, and Wecker E: Downregulation of HLA class I antigens in HIV-1-infected cells. AIDS Res Hum Retroviruses 1989;5:613-620.
42. Noraz N, Verrier B, Fraisier C, and Desgranges C: Cell surface phenotypic changes induced in H9 T cells chronically infected with HTLV type I or HIV type I or coinfected with the two viruses. AIDS Res Hum Retroviruses 1995;11:145-154.
43. Puppo F, Brenci S, Bosco O, Lanza L, Barocci S, Arcangelo N, Ghio M, Contini P, Setti M, Scudeletti M, and Indiveri F: Downregulation of HLA class I antigen expression in CD4+ T lymphocytes from HIV type 1-infected individuals. AIDS Res Hum Retroviruses 1997;13:1509-1516.